Fig. 1 · Structure
Documents & Downloads
Recilisib sodium
Radioprotectant
Recilisib sodium is a radioprotectant that primarily acts by enhancing the activities of AKT and PI3K signaling pathways. This compound demonstrates protective effects against radiation-induced cellular damage, making it valuable for applications in cancer research and radiobiology. Its mechanism of action positions it as a potential therapeutic candidate for improving cellular resilience to ionizing radiation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 922139-31-9 |
| Applications | Radioprotectant |
| Formula | C16H12ClNaO4S |
| Molecular Weight | 358.77 |
| Synonyms | ON 01210 sodium |
| SMILES | O=C(C1=CC=C(C=C1)/C=C/S(=O)(CC2=CC=C(C=C2)Cl)=O)O[Na] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.